These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2588209)

  • 21. Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study.
    Hubbard R; Venn A; Smith C; Cooper M; Johnston I; Britton J
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):743-7. PubMed ID: 9517585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study.
    Hubbard R; Venn A; Lewis S; Britton J
    Am J Respir Crit Care Med; 2000 Jan; 161(1):5-8. PubMed ID: 10619790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lung distensibility and airway function in asthmatic children.
    Kraemer R; Geubelle F
    Pediatr Res; 1984 Nov; 18(11):1154-9. PubMed ID: 6514440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Airway distensibility in adults with asthma and healthy adults, measured by forced oscillation technique.
    Brown NJ; Salome CM; Berend N; Thorpe CW; King GG
    Am J Respir Crit Care Med; 2007 Jul; 176(2):129-37. PubMed ID: 17463413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interrelationship between lung volume, expiratory flow, and lung transfer factor in fibrosing alveolitis.
    Pande JN
    Thorax; 1981 Nov; 36(11):858-62. PubMed ID: 7330809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pressure-volume analysis of the lung with an exponential and linear-exponential model in asthma and COPD. Dutch CNSLD Study Group.
    Bogaard JM; Overbeek SE; Verbraak AF; Vons C; Folgering HT; van der Mark TW; Roos CM; Sterk PJ
    Eur Respir J; 1995 Sep; 8(9):1525-31. PubMed ID: 8575579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic airflow obstruction. Evolution of disordered function in cigarette smokers.
    Colebatch HJ; Greaves IA
    Med J Aust; 1985 May; 142(11):607-10. PubMed ID: 4000025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of hyperinflation on lung elasticity in healthy subjects.
    Hillman DR; Finucane KE
    Respir Physiol; 1983 Dec; 54(3):295-305. PubMed ID: 6369461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung distensibility. The static pressure-volume curve of the lungs and its use in clinical assessment.
    Gibson GJ; Pride NB
    Br J Dis Chest; 1976 Jul; 70(3):143-84. PubMed ID: 791334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of lung distensibility in acromegaly after suppression of growth hormone hypersecretion.
    García-Río F; Pino JM; Díez JJ; Ruíz A; Villasante C; Villamor J
    Am J Respir Crit Care Med; 2001 Sep; 164(5):852-7. PubMed ID: 11549545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lone cryptogenic fibrosing alveolitis: a functional-morphologic correlation based on extent of disease on thin-section computed tomography.
    Wells AU; King AD; Rubens MB; Cramer D; du Bois RM; Hansell DM
    Am J Respir Crit Care Med; 1997 Apr; 155(4):1367-75. PubMed ID: 9105081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis.
    Wallace WA; Roberts SN; Caldwell H; Thornton E; Greening AP; Lamb D; Howie SE
    Thorax; 1994 Mar; 49(3):218-24. PubMed ID: 8202877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Capsaicin induced cough in cryptogenic fibrosing alveolitis.
    Doherty MJ; Mister R; Pearson MG; Calverley PM
    Thorax; 2000 Dec; 55(12):1028-32. PubMed ID: 11083888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional impairment in lone cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a comparison.
    Wells AU; Hansell DM; Rubens MB; Cailes JB; Black CM; du Bois RM
    Am J Respir Crit Care Med; 1997 May; 155(5):1657-64. PubMed ID: 9154872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rising mortality from cryptogenic fibrosing alveolitis.
    Johnston I; Britton J; Kinnear W; Logan R
    BMJ; 1990 Nov; 301(6759):1017-21. PubMed ID: 2249048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.
    Wells AU; Cullinan P; Hansell DM; Rubens MB; Black CM; Newman-Taylor AJ; Du Bois RM
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1583-90. PubMed ID: 8004317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adult height and cryptogenic fibrosing alveolitis: a case-control study using the UK general practice research database.
    Hubbard R; Venn A
    Thorax; 2000 Oct; 55(10):864-6. PubMed ID: 10992540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma lactate dehydrogenase: a marker of disease activity in cryptogenic fibrosing alveolitis and extrinsic allergic alveolitis?
    Matusiewicz SP; Williamson IJ; Sime PJ; Brown PH; Wenham PR; Crompton GK; Greening AP
    Eur Respir J; 1993 Oct; 6(9):1282-6. PubMed ID: 8287944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis.
    Egan JJ; Stewart JP; Hasleton PS; Arrand JR; Carroll KB; Woodcock AA
    Thorax; 1995 Dec; 50(12):1234-9. PubMed ID: 8553293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary mechanics in diffuse fibrosing alveolitis.
    Yernault JC; de Jonghe M; de Coster A; Englert M
    Bull Physiopathol Respir (Nancy); 1975; 11(2):231-44. PubMed ID: 1156719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.